“…In total, 23 in vitro studies met inclusion criteria (published between 2012 and 2019) 8,9,16,[20][21][22][23][24][25][26][27][28][29][30][31][32][33][34][35][36][37][38][39] and most of them (n=18) used permanent teeth (ranging from 30 to 160) for the bonding tests. The bond strength of SAFRCs to primary teeth was evaluated in six studies, published between 2013 and 2019 16,22,26,30,34,38 . Vertise® Flow (Kerr Corp, Orange, CA, USA) (n=22) followed by Fusio™ Liquid Dentin (Pentron Clinical, Orange, CA, USA) (n=5) were the most tested SAFRCs, while Constic® was evaluated only in three studies 29,35,37 .…”